This combination of vital nutrients helps convert fat into energy, supports liver health, and promotes balanced metabolic function
Our team assesses biomarkers, goals, and designs protocolsNAD+ via injections/IVs, 5-Amino-1MQ as capsules/injections
GLP-1 and GIP agonists increase gallbladder disease risk due to reduced gallbladder motility during rapid weight loss
This phase keeps building up B12 stores and helps with recovery
By this point, the peptide has established consistent signaling, and cumulative fat mobilization produces visible changes
5-Amino-1MQ is a selective inhibitor of Nicotinamide N-methyltransferase (NNMT), an enzyme implicated in metabolic dysfunction